Sfoglia per Rivista
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
2019-01-01 Gamucci, T; Pizzuti, L; Natoli, C; Mentuccia, L; Sperduti, I; Barba, M; Sergi, D; Iezzi, L; Maugeri-Sacca, M; Vaccaro, A; Magnolfi, E; Gelibter, A; Barchiesi, G; Magri, V; D'Onofrio, L; Cassano, A; Rossi, E; Botticelli, A; Moscetti, L; Omarini, C; Fabbri, Ma; Scinto, Af; Corsi, D; Carbognin, L; Mazzotta, M; Bria, E; Foglietta, J; Samaritani, R; Garufi, C; Mariani, L; Barni, S; Mirabelli, R; Sarmiento, R; Graziano, V; Santini, D; Marchetti, P; Tonini, G; Di Lauro, L; Sanguineti, G; Paoletti, G; Tomao, S; De Maria, R; Veltri, E; Paris, I; Giotta, F; Latorre, A; Giordano, A; Ciliberto, G; Vici, P
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
2015-01-01 Ciliberto, D; Staropoli, N; Caglioti, F; Gualtieri, S; Fiorillo, L; Chiellino, S; De Angelis, Am; Mendicino, F; Botta, C; Caraglia, M; Tagliaferri, P; Tassone, P
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
2018-01-01 Pizzuti, L; Sergi, D; Sperduti, I; Lauro, Ld; Mazzotta, M; Botti, C; Izzo, F; Marchetti, L; Tomao, S; Marchetti, P; Natoli, C; Grassadonia, A; Gamucci, T; Mentuccia, L; Magnolfi, E; Vaccaro, A; Cassano, A; Rossi, E; Botticelli, A; Sini, V; Sarobba, Mg; Fabbri, Ma; Moscetti, L; Astone, A; Michelotti, A; De Angelis, C; Bertolini, I; Angelini, F; Ciliberto, G; Maugeri-Saccà, M1; Giordano, A; Barba, M; Vici, P
Cancer mortality trends between1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy:Results from a joinpoint regression analysis
2013-01-01 Crispo, A; Barba, M; Malvezzi, M; Arpino, G; Grimaldi, M; Rosso, T; Esposito, E; Sergi, D; Ciliberto, G; Giordano, A; Montella, M
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients
2010-01-01 Correale, P; Remondo, C; Carbone, Sf; Ricci, V; Migali, C; Martellucci, I; Licchetta, A; Addeo, R; Volterrani, L; Gotti, G; Rotundo, Ms; Sperlongano, P; Abbruzzese, A; Caraglia, M; Tagliaferri, P; Francini, G; Tassone, P
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
2009-01-01 Di Martino, Mt; Ventura, M; Pietragalla, A; Cucinotto, I; Calimeri, T; Bulotta, A; Neri, P; Caraglia, M; Tagliaferri, P; Tassone, P
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations.
2012-01-01 Aquino, G; Pannone, G; Santoro, A; Liguori, G; Franco, R; Serpico, R; Florio, G; De Rosa, A; Mattoni, M; Cozza, V; Botti, G; Losito, S; Longo, F; Staibano, S; Cuda, G; Lo Muzio, L; Sbordone, C; Bufo, P; Grimaldi, A; Caraglia, M; Di Domenico, M.
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials
2014-01-01 Staropoli, N; Ciliberto, D; Botta, C; Fiorillo, L; Grimaldi, A; Lama, S; Caraglia, M; Salvino, A; Tagliaferri, P; Tassone, P
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
2011-01-01 Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, G; Romano, O; Abbruzzese, A; Lamberti, M; Luzzi, L; Gotti, G; Rotundo, Ms; Caraglia, M; Tagliaferri, P
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
2009-01-01 Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G
Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
2009-01-01 Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macri, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study
2011-01-01 Di Martino Maria, Teresa; Arbitrio, Mariamena; Leone, Emanuela; Rotundo Maria, Saveria; Ciliberto, Domenico; Tomaino, Vera; Fabiani, Fernanda; Talarico, Danilo; Sperlongano, Pasquale; Cannataro, Mario; Caraglia, Michele; Tagliaferri, P; Cannataro, M; Tassone, P; Doldo, P; Guzzi, P
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro
2014-01-01 Marvaso, G; Barone, A; Amodio, N; Raimondi, L; Altomare, E; Scotti, V; Lombardi, A; Bianco, R; Caraglia, M; Tassone, P; Tagliaferri, P; Agosti, V; Bianco, C
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients.
2013-01-01 Botta, Cirino; Barbieri, Vito; Ciliberto, Domenico; Rossi, Antonio; Rocco, Danilo; Addeo, Raffaele; Staropoli, Nicoletta; Pastina, Pierpaolo; Marvaso, Giulia; Martellucci, Ignazio; Guglielmo, Annamaria; Pirtoli, Luigi; Sperlongano, Pasquale; Gridelli, Cesare; Caraglia, Michele; Tassone, P; Correale, Pierpaolo; Tagliaferri, P
The role of G-CSF in the treatment of advanced tumors
2009-01-01 Bottoni, U; Trapasso, F
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
2016-01-01 Nardone, V; Botta, C; Caraglia, M; Martino, Ec; Ambrosio, Mr; Carfagno, T; Tini, P; Semeraro, L; Misso, G; Grimaldi, A; Boccellino, M; Facchini, G; Berretta, M; Vischi, G; Rocca, Bj; Barone, A; Tassone, P; Tagliaferri, P; Del Vecchio, Mt; Pirtoli, L; Correale, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study | 1-gen-2019 | Gamucci, T; Pizzuti, L; Natoli, C; Mentuccia, L; Sperduti, I; Barba, M; Sergi, D; Iezzi, L; Maugeri-Sacca, M; Vaccaro, A; Magnolfi, E; Gelibter, A; Barchiesi, G; Magri, V; D'Onofrio, L; Cassano, A; Rossi, E; Botticelli, A; Moscetti, L; Omarini, C; Fabbri, Ma; Scinto, Af; Corsi, D; Carbognin, L; Mazzotta, M; Bria, E; Foglietta, J; Samaritani, R; Garufi, C; Mariani, L; Barni, S; Mirabelli, R; Sarmiento, R; Graziano, V; Santini, D; Marchetti, P; Tonini, G; Di Lauro, L; Sanguineti, G; Paoletti, G; Tomao, S; De Maria, R; Veltri, E; Paris, I; Giotta, F; Latorre, A; Giordano, A; Ciliberto, G; Vici, P | |
| A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? | 1-gen-2015 | Ciliberto, D; Staropoli, N; Caglioti, F; Gualtieri, S; Fiorillo, L; Chiellino, S; De Angelis, Am; Mendicino, F; Botta, C; Caraglia, M; Tagliaferri, P; Tassone, P | |
| Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab | 1-gen-2018 | Pizzuti, L; Sergi, D; Sperduti, I; Lauro, Ld; Mazzotta, M; Botti, C; Izzo, F; Marchetti, L; Tomao, S; Marchetti, P; Natoli, C; Grassadonia, A; Gamucci, T; Mentuccia, L; Magnolfi, E; Vaccaro, A; Cassano, A; Rossi, E; Botticelli, A; Sini, V; Sarobba, Mg; Fabbri, Ma; Moscetti, L; Astone, A; Michelotti, A; De Angelis, C; Bertolini, I; Angelini, F; Ciliberto, G; Maugeri-Saccà, M1; Giordano, A; Barba, M; Vici, P | |
| Cancer mortality trends between1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy:Results from a joinpoint regression analysis | 1-gen-2013 | Crispo, A; Barba, M; Malvezzi, M; Arpino, G; Grimaldi, M; Rosso, T; Esposito, E; Sergi, D; Ciliberto, G; Giordano, A; Montella, M | |
| Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients | 1-gen-2010 | Correale, P; Remondo, C; Carbone, Sf; Ricci, V; Migali, C; Martellucci, I; Licchetta, A; Addeo, R; Volterrani, L; Gotti, G; Rotundo, Ms; Sperlongano, P; Abbruzzese, A; Caraglia, M; Tagliaferri, P; Francini, G; Tassone, P | |
| Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo | 1-gen-2009 | Di Martino, Mt; Ventura, M; Pietragalla, A; Cucinotto, I; Calimeri, T; Bulotta, A; Neri, P; Caraglia, M; Tagliaferri, P; Tassone, P | |
| pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations. | 1-gen-2012 | Aquino, G; Pannone, G; Santoro, A; Liguori, G; Franco, R; Serpico, R; Florio, G; De Rosa, A; Mattoni, M; Cozza, V; Botti, G; Losito, S; Longo, F; Staibano, S; Cuda, G; Lo Muzio, L; Sbordone, C; Bufo, P; Grimaldi, A; Caraglia, M; Di Domenico, M. | |
| Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials | 1-gen-2014 | Staropoli, N; Ciliberto, D; Botta, C; Fiorillo, L; Grimaldi, A; Lama, S; Caraglia, M; Salvino, A; Tagliaferri, P; Tassone, P | |
| Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients | 1-gen-2011 | Correale, P; Botta, C; Basile, A; Pagliuchi, M; Licchetta, A; Martellucci, I; Bestoso, E; Apollinari, S; Addeo, R; Misso, G; Romano, O; Abbruzzese, A; Lamberti, M; Luzzi, L; Gotti, G; Rotundo, Ms; Caraglia, M; Tagliaferri, P | |
| Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine | 1-gen-2009 | Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G | |
| Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine | 1-gen-2009 | Correale, P; Miano, St; Remondo, C; Migali, C; Rotundo, Ms; Macri, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G | |
| Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study | 1-gen-2011 | Di Martino Maria, Teresa; Arbitrio, Mariamena; Leone, Emanuela; Rotundo Maria, Saveria; Ciliberto, Domenico; Tomaino, Vera; Fabiani, Fernanda; Talarico, Danilo; Sperlongano, Pasquale; Cannataro, Mario; Caraglia, Michele; Tagliaferri, P; Cannataro, M; Tassone, P; Doldo, P; Guzzi, P | |
| Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro | 1-gen-2014 | Marvaso, G; Barone, A; Amodio, N; Raimondi, L; Altomare, E; Scotti, V; Lombardi, A; Bianco, R; Caraglia, M; Tassone, P; Tagliaferri, P; Agosti, V; Bianco, C | |
| Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. | 1-gen-2013 | Botta, Cirino; Barbieri, Vito; Ciliberto, Domenico; Rossi, Antonio; Rocco, Danilo; Addeo, Raffaele; Staropoli, Nicoletta; Pastina, Pierpaolo; Marvaso, Giulia; Martellucci, Ignazio; Guglielmo, Annamaria; Pirtoli, Luigi; Sperlongano, Pasquale; Gridelli, Cesare; Caraglia, Michele; Tassone, P; Correale, Pierpaolo; Tagliaferri, P | |
| The role of G-CSF in the treatment of advanced tumors | 1-gen-2009 | Bottoni, U; Trapasso, F | |
| Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse | 1-gen-2016 | Nardone, V; Botta, C; Caraglia, M; Martino, Ec; Ambrosio, Mr; Carfagno, T; Tini, P; Semeraro, L; Misso, G; Grimaldi, A; Boccellino, M; Facchini, G; Berretta, M; Vischi, G; Rocca, Bj; Barone, A; Tassone, P; Tagliaferri, P; Del Vecchio, Mt; Pirtoli, L; Correale, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile